Evaluation of the Hepatoprotective Effects of a Nutritional Supplement Containing Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein on Biochemical, Molecular, and Clinical Markers in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study)

What this Trial Is About

Researchers are studying whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein can improve biochemical, molecular, and clinical markers in patients with liver disease caused by chronic hepatitis C infection. The trial compares this supplement to whey protein alone to see if the combination offers extra benefits for liver-related health and clinical outcomes. Participants will take either the investigational supplement or the active control (whey protein alone) daily for 12 weeks. They will attend clinic visits every 4 weeks during this period for laboratory tests and clinical evaluations to monitor progress and effects. During the study, participants will undergo assessments including liver function tests, quality of life questionnaires (CLDQ), and frailty evaluations using grip strength, timed chair stands, and balance tests. Researchers will also measure pro-inflammatory cytokines and antioxidant activity. The study aims to collect these data from enrollment through the 12-week treatment period to evaluate the supplement's impact.

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).